Cargando…
S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428458/ http://dx.doi.org/10.1097/01.HS9.0000967656.64179.85 |
| _version_ | 1785090474224123904 |
|---|---|
| author | Derrien, Jennifer Gastineau, Sarah Frigout, Antoine Giordano, Nils Cherkaoui, Mia Gaborit, Victor Douillard, Elise Devic, Magali Magrangeas, Florence Moreau, Philippe Minvielle, Stéphane Touzeau, Cyrille Letouzé, Eric |
| author_facet | Derrien, Jennifer Gastineau, Sarah Frigout, Antoine Giordano, Nils Cherkaoui, Mia Gaborit, Victor Douillard, Elise Devic, Magali Magrangeas, Florence Moreau, Philippe Minvielle, Stéphane Touzeau, Cyrille Letouzé, Eric |
| author_sort | Derrien, Jennifer |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284582023-08-17 S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA Derrien, Jennifer Gastineau, Sarah Frigout, Antoine Giordano, Nils Cherkaoui, Mia Gaborit, Victor Douillard, Elise Devic, Magali Magrangeas, Florence Moreau, Philippe Minvielle, Stéphane Touzeau, Cyrille Letouzé, Eric Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428458/ http://dx.doi.org/10.1097/01.HS9.0000967656.64179.85 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Derrien, Jennifer Gastineau, Sarah Frigout, Antoine Giordano, Nils Cherkaoui, Mia Gaborit, Victor Douillard, Elise Devic, Magali Magrangeas, Florence Moreau, Philippe Minvielle, Stéphane Touzeau, Cyrille Letouzé, Eric S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA |
| title | S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA |
| title_full | S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA |
| title_fullStr | S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA |
| title_full_unstemmed | S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA |
| title_short | S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA |
| title_sort | s186: acquired resistance to bispecific antibodies by genetic or epigenetic inactivation of the target in multiple myeloma |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428458/ http://dx.doi.org/10.1097/01.HS9.0000967656.64179.85 |
| work_keys_str_mv | AT derrienjennifer s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT gastineausarah s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT frigoutantoine s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT giordanonils s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT cherkaouimia s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT gaboritvictor s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT douillardelise s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT devicmagali s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT magrangeasflorence s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT moreauphilippe s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT minviellestephane s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT touzeaucyrille s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma AT letouzeeric s186acquiredresistancetobispecificantibodiesbygeneticorepigeneticinactivationofthetargetinmultiplemyeloma |